|
|
Volumn 145, Issue 10, 2006, Pages 789-790
|
|
Low-molecular-weight heparin and bleeding: How do we lower risk but maintain benefit?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BLOOD CLOTTING FACTOR 10A;
ENOXAPARIN;
LOW MOLECULAR WEIGHT HEPARIN;
ANTICOAGULANT AGENT;
ANTICOAGULATION;
BLEEDING;
CREATININE CLEARANCE;
DISEASE SEVERITY;
DRUG CLEARANCE;
GLOMERULUS FILTRATION RATE;
HUMAN;
KIDNEY FAILURE;
LETTER;
PRIORITY JOURNAL;
RISK BENEFIT ANALYSIS;
THROMBOEMBOLISM;
CHEMICALLY INDUCED DISORDER;
NOTE;
RISK ASSESSMENT;
ANTICOAGULANTS;
ENOXAPARIN;
HEMORRHAGE;
HUMANS;
RENAL INSUFFICIENCY;
RISK ASSESSMENT;
|
|
EID: 36749064342
PISSN: 00034819
EISSN: None
Source Type: Journal
DOI: 10.7326/0003-4819-145-10-200611210-00018 Document Type: Letter |
|
Times cited : (3)
|
|
References (5)
|
